Trial intelligence / Profile preview

Zanubrutinib versus tacrolimus for primary membranous nephropathy

CTR20230546Phase 3Active

Sponsor

BeiGene

Start

May 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1